Information

Prostate Cancer Voices

Our volunteering group, Voices. Be heard.
Are you African Caribbean? Tell us what you think, influence what we do.

Our specialist nurses

Lots of people have been calling about comments they have heard, or read about, the drug Abiraterone

The Charity has commented on the National Institute of Clinical Excellence (NICE) proposal to not recommend the use of Abiraterone. Abiraterone is a new drug which can help to extend the lives of men with advanced prostate cancer that has stopped responding to other available treatments, including chemotherapy and hormone therapy.

NICE's decision on abiraterone isn't final and the Charity is giving people the opportunity to comment on the draft decision and influence NICE's final recommendation.

About our nurses
Information Standard Certified Member
Donation